Your browser doesn't support javascript.
loading
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.
O'Gorman, Peter; Laubach, Jacob P; O'Dwyer, Michael E; Krawczyk, Janusz; Yee, Andrew J; Gilligan, Oonagh; Cahill, Mary R; Rosenblatt, Jacalyn; Quinn, John; Murphy, Philip T; DiPietro, Heidi; Perera, Meegahage Ratnakanthi; Crotty, Gerard M; Cummings, Kristen; Hayden, Patrick J; Browne, Paul; Savell, Alexandra; O'Leary, Hilary M; O'Keeffe, Denis; Masone, Kelly; Hennessy, Brian J; Guerrero Garcia, Thomas; Scott, Kathleen; Saeed, Khalid; Bianchi, Giada; Dowling, Paul; Tierney, Ciara; Richardson, Paul G.
  • O'Gorman P; Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Laubach JP; Cancer Trials Ireland, Dublin, Ireland.
  • O'Dwyer ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, Massachusetts, USA.
  • Krawczyk J; Department of Haematology, University Hospital Galway, Galway, Ireland.
  • Yee AJ; Department of Haematology, University Hospital Galway, Galway, Ireland.
  • Gilligan O; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
  • Cahill MR; Department of Haematology, Cork University Hospital, Cork, Ireland.
  • Rosenblatt J; Department of Haematology, Cork University Hospital, Cork, Ireland.
  • Quinn J; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Murphy PT; Department of Haematology, Beaumont Hospital, Dublin, Ireland.
  • DiPietro H; Department of Haematology, Beaumont Hospital, Dublin, Ireland.
  • Perera MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, Massachusetts, USA.
  • Crotty GM; Department of Haematology, Midlands Regional Hospital, Tullamore, Ireland.
  • Cummings K; Department of Haematology, Midlands Regional Hospital, Tullamore, Ireland.
  • Hayden PJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, Massachusetts, USA.
  • Browne P; Department of Haematology, St James's Hospital, Dublin, Ireland.
  • Savell A; Department of Haematology, St James's Hospital, Dublin, Ireland.
  • O'Leary HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, Massachusetts, USA.
  • O'Keeffe D; Department of Haematology, University Hospital Limerick, Limerick, Ireland.
  • Masone K; Department of Haematology, University Hospital Limerick, Limerick, Ireland.
  • Hennessy BJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, Massachusetts, USA.
  • Guerrero Garcia T; Department of Haematology, University Hospital Waterford, Waterford, Ireland.
  • Scott K; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, Massachusetts, USA.
  • Saeed K; Cancer Trials Ireland, Dublin, Ireland.
  • Bianchi G; Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Dowling P; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, Massachusetts, USA.
  • Tierney C; Department of Biology, Maynooth University, Maynooth, Kildare, Ireland.
  • Richardson PG; Department of Biology, Maynooth University, Maynooth, Kildare, Ireland.
Am J Hematol ; 97(5): 562-573, 2022 05.
Article en En | MEDLINE | ID: mdl-35132679
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article